PHAR Stock Price, Chart, Stats & News

Pharming Group N.V.
Save
909.21M
Market cap
67.76x
Current P/E
26.81x
Forward P/E
PHAR chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 88.25% |
Operating margin | 5.92% |
Pretax margin | 3.37% |
Net margin | 0.56% |
Effective tax rate | 85.83% |
ROA | 0.48% |
ROE | 0.89% |
D/E | 0.49x |
Interest coverage ratio | 0.02x |
PHAR valuation
P/E | 67.76x |
P/S | 3.00x |
P/B | 4.58x |
P/CF | 22.39x |
P/FCF | 22.75x |
P/OCF | 22.39x |
PEG | 2.93x |
EV multiple | 0.17x |
About
Pharming Group N. V. is a biopharmaceutical company dedicated to the creation and commercialization of protein replacement therapies and precision medicines. The firm concentrates its efforts on addressing rare diseases and critical unmet medical needs across the United States, Europe, and other international markets.
Similar securities
Based on sector and market capitalization
Report issue











